Skip to main content

Table 2 Number of participants who did not complete the entire questionnaire in one session

From: The road to successful people-centric research in rare diseases: the web-based case study of the Immunology and Congenital Disorders of Glycosylation questionnaire (ImmunoCDGQ)

Participant groups

Nº of participants not completing the questionnaire in one session

Nº of days to complete the questionnaire

Immune status

µ

SD

0

1

2

CDG group (Total)

42 out of 209 (20.0%)

21.8

23.5

13 (31%)

24 (57.1%)

5 (11.9%)

 PMM2-CDG group

30 out of 122 (24.6%)

21.2

22.5

9 (30%)

17 (56.7%)

4 (13.3%)

 Non-PMM2-CDG group

12 out of 87 (13.8%)

23.2

26.9

4 (33.3%)

7 (58.3%)

1 (8.3%)

 Control group

0 out of 349 (0%)

NA

  1. Results are presented per participant group and according to the immunological status. Percentages (%) are shown
  2. 0, without immunological involvement; 1, with Immunological involvement; 2, unsolved immune status; NA, not applicable; SD, standard deviation